$MRKR
Marker Therapeutics, Inc.

2018 Q2 Form 10-Q Financial Statement

#000114420418043366 Filed on August 09, 2018

View on sec.gov

Income Statement

Concept 2018 Q2 2017 Q2
Revenue $206.0K $0.00
YoY Change -100.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $3.050M $1.190M
YoY Change 156.3% -4.8%
% of Gross Profit
Research & Development $1.827M $1.203M
YoY Change 51.89% -3.64%
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $4.880M $2.393M
YoY Change 103.9% 91.74%
Operating Profit -$4.674M -$2.393M
YoY Change 95.29% -1.33%
Interest Expense -$140.0K $10.00K
YoY Change -1500.0% -99.88%
% of Operating Profit
Other Income/Expense, Net $0.00
YoY Change -100.0%
Pretax Income -$4.810M -$1.890M
YoY Change 154.5% -131.66%
Income Tax
% Of Pretax Income
Net Earnings -$4.813M -$1.893M
YoY Change 154.19% -131.69%
Net Earnings / Revenue -2336.38%
Basic Earnings Per Share -$0.22
Diluted Earnings Per Share -$406.2K -$0.22
COMMON SHARES
Basic Shares Outstanding 11.84M shares 8.577M shares
Diluted Shares Outstanding 8.577M shares

Balance Sheet

Concept 2018 Q2 2017 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $7.780M $9.960M
YoY Change -21.89% 164.19%
Cash & Equivalents $7.780M $9.960M
Short-Term Investments
Other Short-Term Assets $110.0K $180.0K
YoY Change -38.89% 800.0%
Inventory
Prepaid Expenses $108.7K
Receivables
Other Receivables
Total Short-Term Assets $7.892M $10.14M
YoY Change -22.17% 167.61%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00
YoY Change -100.0%
TOTAL ASSETS
Total Short-Term Assets $7.892M $10.14M
Total Long-Term Assets $0.00 $0.00
Total Assets $7.892M $10.14M
YoY Change -22.17% 167.55%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.600M $1.560M
YoY Change 130.77% 15.56%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $10.00K $10.00K
YoY Change 0.0% -66.67%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.747M $1.580M
YoY Change 137.16% -93.17%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $3.747M $1.580M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $3.747M $1.580M
YoY Change 137.16% -93.17%
SHAREHOLDERS EQUITY
Retained Earnings -$166.2M
YoY Change
Common Stock $13.62K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $4.145M $8.570M
YoY Change
Total Liabilities & Shareholders Equity $7.892M $10.14M
YoY Change -22.17% 167.61%

Cashflow Statement

Concept 2018 Q2 2017 Q2
OPERATING ACTIVITIES
Net Income -$4.813M -$1.893M
YoY Change 154.19% -131.69%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$2.400M -$2.020M
YoY Change 18.81% 3.59%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 7.380M 6.050M
YoY Change 21.98%
NET CHANGE
Cash From Operating Activities -2.400M -2.020M
Cash From Investing Activities
Cash From Financing Activities 7.380M 6.050M
Net Change In Cash 4.980M 4.030M
YoY Change 23.57% -306.67%
FREE CASH FLOW
Cash From Operating Activities -$2.400M -$2.020M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
tpiv Valuation Methodology
ValuationMethodology
<div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">A summary of quantitative information with respect to valuation methodology and significant unobservable inputs used for the Company&#8217;s common stock purchase warrants that are categorized within Level 3 of the fair value hierarchy for the six months ended June 30, 2018 and 2017 is as follows:</div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><div style="color: rgb(0, 0, 0); font: 10pt &quot;times new roman&quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; text-align: justify; background: none;"><div style="text-decoration: none; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><table style="font: 10pt &quot;times new roman&quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; border-collapse: collapse; width: 80%; border-spacing: 0px; margin: 0in auto 0in 0px;;text-align:left;"><tr style="vertical-align:bottom"><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td><td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">June 30,</div></div></td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td><td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">June 30,</div></div></td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td></tr><tr style="vertical-align:bottom"><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td><td style="font-weight: normal; padding-bottom: 1pt; padding-left: 0px; padding-top: 0px; vertical-align: bottom;">&#160;</td><td colspan="2" style="border-bottom: 1pt solid black; font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">2018</div></div></td><td style="padding-bottom: 1pt; font-weight: normal; padding-left: 0px; padding-top: 0px; vertical-align: bottom;">&#160;</td><td style="font-weight: normal; padding-bottom: 1pt; padding-left: 0px; padding-top: 0px; vertical-align: bottom;">&#160;</td><td colspan="2" style="border-bottom: 1pt solid black; font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">2017</div></div></td><td style="padding-bottom: 1pt; font-weight: normal; padding-left: 0px; padding-top: 0px; vertical-align: bottom;">&#160;</td></tr><tr style="vertical-align:bottom; background-color:#cceeff"><td style="width: 1255px; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">Stock price</td><td style="width: 18px; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td><td style="width: 18px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">$</td><td style="width: 216px; text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">9.43</td><td style="width: 18px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td><td style="width: 18px; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td><td style="width: 17px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">$</td><td style="width: 215px; text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">3.88</td><td style="width: 17px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td></tr><tr style="vertical-align:bottom; background-color:white"><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">Exercise price</td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td><td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">$</td><td style="text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">8.67</td><td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td><td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">$</td><td style="text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">1.20</td><td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td></tr><tr style="vertical-align:bottom; background-color:#cceeff"><td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">Contractual term (years)</td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td><td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td><td style="text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">1.32</td><td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td><td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td><td style="text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">1.03</td><td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td></tr><tr style="vertical-align:bottom; background-color:white"><td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">Volatility (annual)</td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td><td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td><td style="text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">83</td><td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">%</td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td><td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td><td style="text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">78</td><td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">%</td></tr><tr style="vertical-align:bottom; background-color:#cceeff"><td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">Risk-free rate</td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td><td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td><td style="text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">1</td><td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">%</td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td><td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td><td style="text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">1</td><td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">%</td></tr><tr style="vertical-align:bottom; background-color:white"><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">Dividend yield (per share)</td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td><td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td><td style="text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">0</td><td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">%</td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td><td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td><td style="text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">0</td><td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">%</td></tr></table><div style="clear:both;"></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
us-gaap Nature Of Operations
NatureOfOperations
<div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-transform: uppercase; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Note 1: Nature of Operations</div></div></div><div style="background: none; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="background: rgb(255, 255, 255); font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">TapImmune Inc. (the &#8220;Company&#8221; or &#8220;we&#8221;), a Nevada corporation incorporated in 1991, is a biotechnology company focusing on immunotherapy specializing in the development of innovative peptide and gene-based immunotherapeutics and vaccines for the treatment of oncology. Unlike other vaccine technologies that narrowly address the initiation of an immune response, TapImmune's approach broadly stimulates the cellular immune system by enhancing the function of killer T-cells and T-helper cells and by restoring antigen presentation in tumor cells allowing their recognition&#160;by the immune system.</div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
us-gaap Basis Of Accounting
BasisOfAccounting
<div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-transform: uppercase; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">NOTE 2: Basis of Presentation</div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;) for interim financial information and pursuant to the instructions to Form 10-Q and Article 8 of Regulation S-X of the Securities and Exchange Commission (&#8220;SEC&#8221;) and on the same basis as the Company prepares its annual audited consolidated financial statements. In the opinion of management, the accompanying unaudited condensed consolidated financial statements reflect all adjustments, consisting of normal recurring adjustments, considered necessary for a fair presentation of such interim results.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The results for the condensed consolidated statement of operations are not necessarily indicative of results to be expected for the year ending December 31, 2018 or for any future interim period. The condensed consolidated balance sheet at June 30, 2018 has been derived from unaudited financial statements; however, it does not include all of the information and notes required by U.S. GAAP for complete financial statements. The accompanying condensed consolidated financial statements should be read in conjunction with the consolidated financial statements for the year ended December 31, 2017, and notes thereto included in the Company&#8217;s annual report on Form 10-K filed on March 23, 2018.</div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
tpiv Financial Assets And Liabilities Measured At Fair Value On Recurring Basis
FinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasis
<div style="color: rgb(0, 0, 0); font: 10pt &quot;times new roman&quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; text-align: justify;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Financial liabilities measured at fair value on a recurring basis are summarized below and disclosed on the balance sheet under Warrant liability:</div></div><div style="color: rgb(0, 0, 0); font: 10pt &quot;times new roman&quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; text-align: justify; background: none;"><div style="text-decoration: none; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><table style="font: 10pt &quot;times new roman&quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; border-collapse: collapse; width: 99%; border-spacing: 0px;"><tr style="vertical-align:bottom"><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="font-weight: normal; padding-bottom: 1pt; padding-left: 0px; padding-top: 0px;">&#160;</td><td colspan="14" style="border-bottom: 1pt solid black; font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">Fair value measured at June 30, 2018</div></div></td><td style="padding-bottom: 1pt; font-weight: normal; padding-left: 0px; padding-top: 0px;">&#160;</td></tr><tr style="vertical-align:bottom"><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">Quoted prices in active</div></div></td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">Significant other</div></div></td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">Significant</div></div></td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td colspan="2" style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td></tr><tr style="vertical-align:bottom"><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">markets</div></div></td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">observable inputs</div></div></td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">unobservable inputs</div></div></td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">Fair value at</div></div></td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td></tr><tr style="vertical-align:bottom"><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="font-weight: normal; padding-bottom: 1pt; padding-left: 0px; padding-top: 0px;">&#160;</td><td colspan="2" style="border-bottom: 1pt solid black; font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">(Level 1)</div></div></td><td style="padding-bottom: 1pt; font-weight: normal; padding-left: 0px; padding-top: 0px;">&#160;</td><td style="font-weight: normal; padding-bottom: 1pt; padding-left: 0px; padding-top: 0px;">&#160;</td><td colspan="2" style="border-bottom: 1pt solid black; font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">(Level 2)</div></div></td><td style="padding-bottom: 1pt; font-weight: normal; padding-left: 0px; padding-top: 0px;">&#160;</td><td style="font-weight: normal; padding-bottom: 1pt; padding-left: 0px; padding-top: 0px;">&#160;</td><td colspan="2" style="border-bottom: 1pt solid black; font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">(Level 3)</div></div></td><td style="padding-bottom: 1pt; font-weight: normal; padding-left: 0px; padding-top: 0px;">&#160;</td><td style="font-weight: normal; padding-bottom: 1pt; padding-left: 0px; padding-top: 0px;">&#160;</td><td colspan="2" style="border-bottom: 1pt solid black; font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">June 30, 2018</div></div></td><td style="padding-bottom: 1pt; font-weight: normal; padding-left: 0px; padding-top: 0px;">&#160;</td></tr><tr style="vertical-align:bottom; background-color:#cceeff"><td style="width: 755px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">Warrant liability</td><td style="width: 19px; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="width: 19px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">$</td><td style="width: 227px; text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">-</td><td style="width: 19px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="width: 19px; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="width: 19px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">$</td><td style="width: 227px; text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">-</td><td style="width: 19px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="width: 19px; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="width: 19px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">$</td><td style="width: 227px; text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">147,000</td><td style="width: 19px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="width: 18px; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="width: 18px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">$</td><td style="width: 226px; text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">147,000</td><td style="width: 18px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td></tr></table><div style="clear: both; background: none;"></div><div style="color: rgb(0, 0, 0); font: 10pt &quot;times new roman&quot;, times, serif; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; background: none;"><div style="text-decoration: none; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><table style="font: 10pt &quot;times new roman&quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; border-collapse: collapse; width: 99%; border-spacing: 0px;"><tr style="vertical-align:bottom"><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="font-weight: normal; padding-bottom: 1pt; padding-left: 0px; padding-top: 0px;">&#160;</td><td colspan="14" style="border-bottom: 1pt solid black; font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">Fair value measured at December 31, 2017</div></div></td><td style="padding-bottom: 1pt; font-weight: normal; padding-left: 0px; padding-top: 0px;">&#160;</td></tr><tr style="vertical-align:bottom"><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">Quoted prices in active</div></div></td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">Significant other</div></div></td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">Significant</div></div></td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td colspan="2" style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td></tr><tr style="vertical-align:bottom"><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">markets</div></div></td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">observable inputs</div></div></td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">unobservable inputs</div></div></td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">Fair value at</div></div></td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td></tr><tr style="vertical-align:bottom"><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="font-weight: normal; padding-bottom: 1pt; padding-left: 0px; padding-top: 0px;">&#160;</td><td colspan="2" style="border-bottom: 1pt solid black; font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">(Level 1)</div></div></td><td style="padding-bottom: 1pt; font-weight: normal; padding-left: 0px; padding-top: 0px;">&#160;</td><td style="font-weight: normal; padding-bottom: 1pt; padding-left: 0px; padding-top: 0px;">&#160;</td><td colspan="2" style="border-bottom: 1pt solid black; font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">(Level 2)</div></div></td><td style="padding-bottom: 1pt; font-weight: normal; padding-left: 0px; padding-top: 0px;">&#160;</td><td style="font-weight: normal; padding-bottom: 1pt; padding-left: 0px; padding-top: 0px;">&#160;</td><td colspan="2" style="border-bottom: 1pt solid black; font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">(Level 3)</div></div></td><td style="padding-bottom: 1pt; font-weight: normal; padding-left: 0px; padding-top: 0px;">&#160;</td><td style="font-weight: normal; padding-bottom: 1pt; padding-left: 0px; padding-top: 0px;">&#160;</td><td colspan="2" style="border-bottom: 1pt solid black; font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">December 31, 2017</div></div></td><td style="padding-bottom: 1pt; font-weight: normal; padding-left: 0px; padding-top: 0px;">&#160;</td></tr><tr style="vertical-align:bottom; background-color:#cceeff"><td style="width: 755px; text-align: justify; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">Warrant liability</td><td style="width: 19px; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="width: 19px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">$</td><td style="width: 227px; text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">-</td><td style="width: 19px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="width: 19px; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="width: 19px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">$</td><td style="width: 227px; text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">-</td><td style="width: 19px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="width: 19px; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="width: 19px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">$</td><td style="width: 227px; text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">9,000</td><td style="width: 19px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="width: 18px; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="width: 18px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">$</td><td style="width: 226px; text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">9,000</td><td style="width: 18px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td></tr></table><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
tpiv Measured At Fair Value
MeasuredAtFairValue
<div style="color: rgb(0, 0, 0); font: 10pt &quot;times new roman&quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; text-align: justify;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The following table presents changes in Level 3 liabilities measured at fair value for the six months ended June 30, 2018:</div></div><div style="color: rgb(0, 0, 0); font: 10pt &quot;times new roman&quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; text-align: justify; background: none;"><div style="text-decoration: none; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><table style="font: 10pt &quot;times new roman&quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; border-collapse: collapse; width: 69%; border-spacing: 0px;"><tr style="vertical-align:bottom"><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">Warrant</div></div></td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td></tr><tr style="vertical-align:bottom"><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="font-weight: normal; padding-bottom: 1pt; padding-left: 0px; padding-top: 0px;">&#160;</td><td colspan="2" style="border-bottom: 1pt solid black; font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">Liability</div></div></td><td style="padding-bottom: 1pt; font-weight: normal; padding-left: 0px; padding-top: 0px;">&#160;</td></tr><tr style="vertical-align:bottom; background-color:#cceeff"><td style="width: 1083px; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">Balance - December 31, 2017</td><td style="width: 40px; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="width: 13px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">$</td><td style="width: 158px; text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">9,000</td><td style="width: 26px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td></tr><tr style="vertical-align:bottom; background-color:white"><td style="text-align: left; padding-bottom: 1pt; padding-left: 9pt; padding-top: 0px;">Change in fair value of warrant liability</td><td style="padding-bottom: 1pt; padding-left: 0px; padding-top: 0px;">&#160;</td><td style="border-bottom: 1pt solid black; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="border-bottom: 1pt solid black; text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">138,000</td><td style="padding-bottom: 1pt; text-align: left; padding-left: 0px; padding-top: 0px;">&#160;</td></tr><tr style="vertical-align:bottom; background-color:#cceeff"><td style="padding-bottom: 2.5pt; padding-left: 0px; padding-top: 0px;">Balance &#8211; June 30, 2018</td><td style="padding-bottom: 2.5pt; padding-left: 0px; padding-top: 0px;">&#160;</td><td style="border-bottom: 2.5pt double black; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">$</td><td style="border-bottom: 2.5pt double black; text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">147,000</td><td style="padding-bottom: 2.5pt; text-align: left; padding-left: 0px; padding-top: 0px;">&#160;</td></tr></table><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2018Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
7800000 USD
us-gaap Option Indexed To Issuers Equity Shares
OptionIndexedToIssuersEquityShares
439000 shares
us-gaap Option Indexed To Issuers Equity Shares
OptionIndexedToIssuersEquityShares
455000 shares
CY2017Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
9000 USD
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
138000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3426387 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2191817 USD
CY2018Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1826837 USD
CY2017Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1202725 USD
tpiv Common Stock Warrants Equity Treatment
CommonStockWarrantsEquityTreatment
4871000 shares
tpiv Common Stock Warrants Equity Treatment
CommonStockWarrantsEquityTreatment
6544000 shares
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-4812797 USD
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
-1893377 USD
us-gaap Net Income Loss
NetIncomeLoss
-8009283 USD
us-gaap Net Income Loss
NetIncomeLoss
-4313262 USD
us-gaap Net Income Loss
NetIncomeLoss
-4313262 USD
dei Document Type
DocumentType
10-Q
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5310000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6999000 shares
CY2018Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3052954 USD
CY2017Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1190517 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4650890 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2618310 USD
CY2018Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
147000 USD
CY2018Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2018Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2018Q2 us-gaap Operating Expenses
OperatingExpenses
4879791 USD
CY2017Q2 us-gaap Operating Expenses
OperatingExpenses
2393242 USD
us-gaap Operating Expenses
OperatingExpenses
8077277 USD
us-gaap Operating Expenses
OperatingExpenses
4810127 USD
CY2018Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11838371 shares
CY2017Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8576634 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11233755 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8503521 shares
us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
-4500 USD
us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
138000 USD
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
3658127 USD
us-gaap Share Based Compensation
ShareBasedCompensation
647387 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1096472 USD
dei Document Period End Date
DocumentPeriodEndDate
2018-06-30
CY2018Q2 us-gaap Cash
Cash
7782962 USD
CY2017Q4 us-gaap Cash
Cash
5129289 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-7871283 USD
dei Amendment Flag
AmendmentFlag
false
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.51
us-gaap Operating Income Loss
OperatingIncomeLoss
-4810127 USD
CY2018Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-4673797 USD
CY2017Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2393242 USD
CY2018Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
108716 USD
CY2017Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
51150 USD
CY2018Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.41
CY2017Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.22
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.71
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2018
tpiv Private Placement Amount
PrivatePlacementAmount
3120000 USD
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
109032 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
57566 USD
CY2018Q2 us-gaap Assets Current
AssetsCurrent
7891678 USD
CY2017Q4 us-gaap Assets Current
AssetsCurrent
5180439 USD
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q2 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-139000 USD
CY2017Q2 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
7500 USD
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-138000 USD
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
4500 USD
CY2018Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
41700000 shares
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
41700000 shares
CY2018Q2 us-gaap Assets
Assets
7891678 USD
CY2017Q4 us-gaap Assets
Assets
5180439 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
336135 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2086840 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
18125 USD
dei Entity Registrant Name
EntityRegistrantName
TAPIMMUNE INC.
CY2018Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2017Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
492365 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
492365 USD
dei Entity Central Index Key
EntityCentralIndexKey
0001094038
dei Trading Symbol
TradingSymbol
TPIV
CY2018Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
13710544 shares
us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
2111372 USD
us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
2653673 USD
CY2018Q2 us-gaap Notes Payable Current
NotesPayableCurrent
5000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3935637 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4745537 USD
CY2018Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13600000 shares
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10600000 shares
CY2018Q2 us-gaap Share Based Compensation
ShareBasedCompensation
960000 USD
CY2017Q2 us-gaap Share Based Compensation
ShareBasedCompensation
271000 USD
CY2018Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
159000 USD
CY2017Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.22
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.51
CY2018Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13600000 shares
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10600000 shares
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
tpiv Proceeds From Issuance Of Common Stock And Warrants In Private Placement
ProceedsFromIssuanceOfCommonStockAndWarrantsInPrivatePlacement
3120000 USD
tpiv Proceeds From Issuance Of Common Stock And Warrants In Private Placement
ProceedsFromIssuanceOfCommonStockAndWarrantsInPrivatePlacement
5408343 USD
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P5M23D
CY2018Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
3595152 USD
CY2017Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1508312 USD
CY2018Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
147000 USD
CY2017Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
9000 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
4261085 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
638666 USD
CY2017Q4 us-gaap Notes Payable Current
NotesPayableCurrent
5000 USD
CY2018Q2 us-gaap Liabilities Current
LiabilitiesCurrent
3747152 USD
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1522312 USD
CY2016Q4 us-gaap Cash
Cash
7851243 USD
CY2017Q2 us-gaap Cash
Cash
9962615 USD
CY2018Q2 us-gaap Liabilities
Liabilities
3747152 USD
CY2017Q4 us-gaap Liabilities
Liabilities
1522312 USD
CY2018Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2018Q2 us-gaap Common Stock Value
CommonStockValue
13624 USD
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
10616 USD
CY2018Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
170287725 USD
CY2017Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
161067538 USD
CY2018Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-166156823 USD
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-157420027 USD
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
4144526 USD
CY2018Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7891678 USD
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5180439 USD
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
11233755 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
8503521 shares
CY2018Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
11838371 shares
CY2017Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
8576634 shares
CY2018Q2 us-gaap Revenues
Revenues
205994 USD
CY2017Q2 us-gaap Revenues
Revenues
0 USD
us-gaap Revenues
Revenues
205994 USD
us-gaap Revenues
Revenues
0 USD
tpiv Exercise Of Warrants Amount
ExerciseOfWarrantsAmount
4261085 USD
tpiv Warrant Of Cashless Exercised
WarrantOfCashlessExercised
0 USD
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1096472 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
492365 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
18125 USD
CY2017Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
6520000 shares
tpiv Number Of Warrant Issued
NumberOfWarrantIssued
0 shares
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6047009 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
7399210 USD
tpiv Noncash Or Part Noncash Transaction Fair Value Of Repriced Warrants As Inducement
NoncashOrPartNoncashTransactionFairValueOfRepricedWarrantsAsInducement
727513 USD
tpiv Noncash Or Part Noncash Transaction Fair Value Of Repriced Warrants As Inducement
NoncashOrPartNoncashTransactionFairValueOfRepricedWarrantsAsInducement
622042 USD
tpiv Number Of Warrants Cashless Exercised
NumberOfWarrantsCashlessExercised
-118000 shares
tpiv Number Of Warrant Exercised For Cash
NumberOfWarrantExercisedForCash
-1447000 shares
tpiv Number Of Warrant Expired Or Cancelled
NumberOfWarrantExpiredOrCancelled
-84000 shares
CY2018Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
4871000 shares
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
0 USD
CY2017Q4 tpiv Class Of Warrant Or Rights Out Standing Weighted Average Exercise Price
ClassOfWarrantOrRightsOutStandingWeightedAverageExercisePrice
6.11
tpiv Class Of Warrant Or Rights Out Standing Issued Weighted Average Exercise Price
ClassOfWarrantOrRightsOutStandingIssuedWeightedAverageExercisePrice
0
tpiv Class Of Warrant Or Rights Outstanding Cashless Exercised Weighted Average Exercise Price
ClassOfWarrantOrRightsOutstandingCashlessExercisedWeightedAverageExercisePrice
4.01
tpiv Class Of Warrant Or Rights Outstanding Exercised Weighted Average Exercised For Cash
ClassOfWarrantOrRightsOutstandingExercisedWeightedAverageExercisedForCash
2.95
tpiv Class Of Warrant Or Rights Outstanding Expired Or Cancelled Weighted Average Exercise Price
ClassOfWarrantOrRightsOutstandingExpiredOrCancelledWeightedAverageExercisePrice
4.01
CY2018Q2 tpiv Class Of Warrant Or Rights Out Standing Weighted Average Exercise Price
ClassOfWarrantOrRightsOutStandingWeightedAverageExercisePrice
5.94
tpiv Class Of Warrant Or Rights Out Standing Weighted Average Remaining Contractual Life
ClassOfWarrantOrRightsOutStandingWeightedAverageRemainingContractualLife
P2Y9M4D
CY2017 tpiv Class Of Warrant Or Rights Out Standing Weighted Average Remaining Contractual Life
ClassOfWarrantOrRightsOutStandingWeightedAverageRemainingContractualLife
P3Y1M28D
CY2018Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1300000 shares
CY2018Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
2.50
CY2018Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3120000 USD
CY2018Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
782505 shares
CY2018Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
782800 shares
CY2018Q2 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
2000000 USD
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
-1893377 USD
CY2017Q4 tpiv Class Of Warrant Or Right Out Standing Intrinsic Value
ClassOfWarrantOrRightOutStandingIntrinsicValue
1739000 USD
CY2018Q2 tpiv Class Of Warrant Or Right Out Standing Intrinsic Value
ClassOfWarrantOrRightOutStandingIntrinsicValue
20417000 USD
tpiv Non Cash Excercise Of Warrants Amount
NonCashExcerciseOfWarrantsAmount
118 USD
tpiv Non Cash Excercise Of Warrants Amount
NonCashExcerciseOfWarrantsAmount
0 USD

Files In Submission

Name View Source Status
0001144204-18-043366-index-headers.html Edgar Link pending
0001144204-18-043366-index.html Edgar Link pending
0001144204-18-043366.txt Edgar Link pending
0001144204-18-043366-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tpiv-20180630.xml Edgar Link completed
tpiv-20180630.xsd Edgar Link pending
tpiv-20180630_cal.xml Edgar Link unprocessable
tpiv-20180630_def.xml Edgar Link unprocessable
tpiv-20180630_lab.xml Edgar Link unprocessable
tpiv-20180630_pre.xml Edgar Link unprocessable
tv499451_10q.htm Edgar Link pending
tv499451_ex31-1.htm Edgar Link pending
tv499451_ex31-2.htm Edgar Link pending
tv499451_ex32-1.htm Edgar Link pending
tv499451_ex32-2.htm Edgar Link pending
tv499451_img01.jpg Edgar Link pending
tv499451_img02.jpg Edgar Link pending